Cargando…

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease

Cholesterol-rich, apolipoprotein B (apoB)-containing lipoproteins are now widely accepted as the most important causal agents of atherosclerotic cardiovascular disease. Multiple unequivocal and orthogonal lines of evidence all converge on low-density lipoprotein and related particles as being the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shapiro, Michael D., Fazio, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310383/
https://www.ncbi.nlm.nih.gov/pubmed/28299190
http://dx.doi.org/10.12688/f1000research.9845.1
_version_ 1782507860344700928
author Shapiro, Michael D.
Fazio, Sergio
author_facet Shapiro, Michael D.
Fazio, Sergio
author_sort Shapiro, Michael D.
collection PubMed
description Cholesterol-rich, apolipoprotein B (apoB)-containing lipoproteins are now widely accepted as the most important causal agents of atherosclerotic cardiovascular disease. Multiple unequivocal and orthogonal lines of evidence all converge on low-density lipoprotein and related particles as being the principal actors in the genesis of atherosclerosis. Here, we review the fundamental role of atherogenic apoB-containing lipoproteins in cardiovascular disease and several other humoral and parietal factors that are required to initiate and maintain arterial degeneration. The biology of foam cells and their interactions with high-density lipoproteins, including cholesterol efflux, are also briefly reviewed.
format Online
Article
Text
id pubmed-5310383
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-53103832017-03-14 Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease Shapiro, Michael D. Fazio, Sergio F1000Res Review Cholesterol-rich, apolipoprotein B (apoB)-containing lipoproteins are now widely accepted as the most important causal agents of atherosclerotic cardiovascular disease. Multiple unequivocal and orthogonal lines of evidence all converge on low-density lipoprotein and related particles as being the principal actors in the genesis of atherosclerosis. Here, we review the fundamental role of atherogenic apoB-containing lipoproteins in cardiovascular disease and several other humoral and parietal factors that are required to initiate and maintain arterial degeneration. The biology of foam cells and their interactions with high-density lipoproteins, including cholesterol efflux, are also briefly reviewed. F1000Research 2017-02-13 /pmc/articles/PMC5310383/ /pubmed/28299190 http://dx.doi.org/10.12688/f1000research.9845.1 Text en Copyright: © 2017 Shapiro MD and Fazio S http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Shapiro, Michael D.
Fazio, Sergio
Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
title Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
title_full Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
title_fullStr Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
title_full_unstemmed Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
title_short Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
title_sort apolipoprotein b-containing lipoproteins and atherosclerotic cardiovascular disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310383/
https://www.ncbi.nlm.nih.gov/pubmed/28299190
http://dx.doi.org/10.12688/f1000research.9845.1
work_keys_str_mv AT shapiromichaeld apolipoproteinbcontaininglipoproteinsandatheroscleroticcardiovasculardisease
AT faziosergio apolipoproteinbcontaininglipoproteinsandatheroscleroticcardiovasculardisease